IDV vehicle
36F79718D0275
65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | NAC FEDERAL SUPPLY SCHEDULE (36F797) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIXED PRICE WITH ECONOMIC PRICE ADJUSTMENT |
| Obligations | $0 |
| Current contract value | Not reported |
| Potential contract value / ceiling | $761.6M |
| Start date | Nov 1, 2017 |
| Current end date | Not available |
| Potential end date | Not available |
| Latest award activity | Aug 18, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 46 of 46 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 18, 2026 | P00045 | $0 | PRODUCT DELETIONS AND CONTRACT CANCELLATION |
| Mar 25, 2026 | P00043 | $0 | 2026 SMALL BUSINESS SUBCONTRACTING PLAN |
| Mar 20, 2026 | P00044 | $0 | UPDATE TO SIGNATORY AUTHORITY FORM |
| Feb 23, 2026 | P00042 | $0 | TEMPORARY CONTRACT EXTENSION AND POC CHANGES |
| Jan 30, 2026 | P00041 | $0 | PERMANENT PRICE REDUCTIONS |
| Dec 8, 2025 | P00040 | $0 | 2026 PUBLIC LAW PRICING UPDATE |
| Aug 18, 2025 | P00039 | $0 | TEMPORARY CONTRACT EXTENSION |
| Mar 27, 2025 | P00038 | $0 | 2025 SMALL BUSINESS SUBCONTRACTING PLAN |
| Mar 5, 2025 | P00037 | $0 | VENDOR REQUESTS AN ADMINISTRATIVE CHANGE |
| Mar 4, 2025 | P00036 | $0 | 65IB: SIN 42-A - PRODUCT DELETIONS |
| Feb 12, 2025 | P00035 | $0 | 6-MONTH TEMPORARY CONTRACT EXTENSION |
| Dec 6, 2024 | P00034 | $0 | FSS |
| Sep 3, 2024 | P00033 | $0 | FSS |
| Apr 22, 2024 | P00031 | $0 | SUBCONTRACTING PLAN |
| Apr 22, 2024 | P00032 | $0 | FSS |
| Dec 22, 2023 | P00030 | $0 | PUBLIC LAW 2024 PRICING UPDATES. |
| Nov 13, 2023 | P00029 | $0 | TEMPORARY CONTRACT EXTENSION THRU 9/30/2024. |
| May 2, 2023 | P00028 | $0 | ADMINISTRATIVE MODIFICATION. |
| Apr 20, 2023 | P00027 | $0 | SIGNATORY AUTHORITY CHANGE. |
| Feb 22, 2023 | P00025 | $0 | TEMPORARY CONTRACT EXTENSION THRU 3/31/2024 |
| Feb 22, 2023 | P00026 | $0 | LIFECYCLE CHANGE TO PERMANENT FCP ON IMBRUVICA 70MG/ML. |
| Jan 20, 2023 | P00023 | $0 | PRODUCT ADDITION OF IMBRUVICA (1). |
| Jan 17, 2023 | P00024 | $0 | SUBCONTRACTING PLAN FOR 2023. |
| Dec 15, 2022 | P00022 | $0 | TPR |
| Dec 1, 2022 | P00021 | $0 | PUBLIC LAW 2023 PRICING UPDATES. |
| Oct 28, 2022 | P00020 | $0 | TEMPORARY PRICE REDUCTION MODIFICATION. |
| Oct 14, 2022 | P00019 | $0 | TPR MODIFICATION. |
| Sep 13, 2022 | P00018 | $0 | SALES POC AND AGENT RECOGNITION. |
| Sep 6, 2022 | P00017 | $0 | TEMPORARY CONTRACT EXTENSION MODIFICATION. |
| Jan 1, 2022 | P00016 | $0 | 2022 SUBCONTRACTING PLAN. |
| Dec 21, 2021 | P00015 | $0 | PUBLIC LAW 2022 UPDATED PRICING. |
| Oct 5, 2021 | P00014 | $0 | ADDRESS CHANGE. |
| Jun 16, 2021 | P00013 | $0 | SIGNATORY AUTHORITY CHANGE. |
| Feb 5, 2021 | P00012 | $0 | SUBCONTRACTING PLAN FOR 2021. |
| Dec 23, 2020 | P00011 | $0 | PUBLIC LAW PRICING UPDATES. |
| Mar 6, 2020 | P00010 | $0 | SUBCONTRACTING PLAN FOR 2020. |
| Dec 20, 2019 | P00009 | $0 | PUBLIC LAW 2020 PRICING UPDATES. |
| Feb 28, 2019 | P00008 | $0 | SUBCONTRACTING PLAN FROM 1/1/2019 THRU 12/31/2019. |
| Dec 18, 2018 | P00007 | $0 | PUBLIC LAW 2019. |
| Sep 26, 2018 | P00006 | $0 | FCP LIFECYCLE CHANGE TO PERMANENT FCP ON FIVE (5) IMBRUVICA PRODUCTS. |
| Jul 13, 2018 | P00005 | $0 | LIFECYCLE CHANGE TO TEMPORARY FCP ON FOUR (4) IMBRUVICA PRODUCTS. |
| Jul 5, 2018 | P00004 | $0 | POC CHANGE. |
| Jun 12, 2018 | P00003 | $0 | LIFECYCLE CHANGE TO TEMPORARY FCP ON ONE (1) IMBRUVICA. |
| Apr 16, 2018 | P00002 | $0 | ADD |
| Dec 5, 2017 | P00001 | $0 | PL 2018 |
| Oct 17, 2017 | 0 | $0 | 65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.